Brief: BrightPath Biotherapeutics says exercise of options

BrightPath Biotherapeutics Co

26/01/2018 08:09

Jan 26(Reuters) - BrightPath Biotherapeutics Co Ltd  4594.T  
     
    * Says 10,300 units of its 12th series options were 
exercised to 1 
million shares of its common stock, during the period from Jan. 
23 to Jan. 26 
 
     
     
    Source text in Japanese:https://goo.gl/6tUUPd 
    Further company coverage: 4594.T  
 
 (Beijing Headline News) 
 ((Beijing.HeadlineNews@thomsonreuters.com; +86 10 62674724; 
Reuters Messaging: huafang.zhang.reuters.com@reuters.net))